Publication and Reporting of the Results of Postmarket Studies for Drugs Required by the US Food and Drug Administration, 2009 to 2013.
Where this comes from
- Record sourced from PubMed, PMID 28505214.
- Also identified by DOI 10.1001/jamainternmed.2017.1313 and PMC identifier 5818792.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study describes publication rates and characteristics of postmarket drug studies by application type, regulatory authority, study type, and drug class.
Medical subject headings
- Product Surveillance, Postmarketing